View all cases
UPC APP 47154/2024
Aug 14, 2024·EP3666797 +1 more: ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
- Case details
- StatusWritten PhaseActionGenericCategoryDocument Access (RoP262)
- Parties
- Division
- Munich CD
- Technology
- Biotechnology
- Language
- English
- First decided
- Oct 22, 2024
Decisions
- 2024-10-22Application RoP262.1 (b)
The Munich Central Division Section ruled on a third-party access application (R. 262.1(b) RoP) by Dehns (a large UPC representative firm) seeking access to all written pleadings and evidence in the Amgen-Regeneron revocation and counterclaim proceedings concerning EP 3 666 797 (decided on 16 July 2024). The court distinguished between procedural documents falling and not falling within the categories of 'written pleadings' and 'evidence', granting access to the qualifying documents.
Legal issues:Third-party access to court file (R. 262.1(b) RoP)Definition of 'written pleadings' and 'evidence'Professional representative's interest in understanding court procedure
Documents
| Document title | Date | Public |
|---|---|---|
| Procedural Order App_47154/2024 | 2024-10-23 | Not public |
| Headnote-and-Keywords | 2024-10-22 | Not public |
| Outcome of the Order | 2024-10-22 | Not public |
| 262.1(b) order | 2024-10-22 | Public |
| 262.1(b) order | 2024-10-22 | Not public |
| Template-Order | 2024-10-22 | Not public |
| opportunity to comment for applicant | 2024-09-10 | Not public |
| US Delaware District Court Memorandum Order | 2024-08-29 | Not public |
| 2024.08.29 - Response re Dehns access request (Sanofi and Regen) - signed | 2024-08-29 | Not public |
| Reply to RoP 262.1 (b) | 2024-08-22 | Not public |
| Opportunity to comment | 2024-08-15 | Not public |
| Access Request under RoP262.1(b) | 2024-08-14 | Not public |